Clinical Trial Transparency & Disclosure

How to Design Sponsor Transparency Governance That Meets FDA, EMA and MHRA Expectations How to Design Sponsor Transparency Governance That Meets FDA, EMA and MHRA Expectations In the landscape of clinical research and trials, transparency governance serves as a cornerstone to ensure compliance, enhance trust, and facilitate ethical engagements. Regulatory agencies including the FDA, EMA,…

Read More “How to Design Sponsor Transparency Governance That Meets FDA, EMA and MHRA Expectations” »

Sponsor Transparency Governance: Compliance Strategy for US, EU and UK Clinical Programs Sponsor Transparency Governance: Compliance Strategy for US, EU and UK Clinical Programs Sponsor transparency governance is a critical element in the landscape of clinical research and trials, particularly as regulatory frameworks across jurisdictions become increasingly stringent. Compliance with transparent practices not only helps…

Read More “Sponsor Transparency Governance: Compliance Strategy for US, EU and UK Clinical Programs” »

Common Pitfalls in Sponsor Transparency Governance—and How to Avoid Costly Findings Common Pitfalls in Sponsor Transparency Governance—and How to Avoid Costly Findings Effective governance in clinical trials is paramount for ensuring compliance with regulatory standards and safeguarding patient interests. This tutorial provides a comprehensive guide for clinical operations, regulatory affairs, and medical affairs professionals to…

Read More “Common Pitfalls in Sponsor Transparency Governance—and How to Avoid Costly Findings” »

Sponsor Transparency Governance in Practice: Step-by-Step Guide for Sponsors and CROs Sponsor Transparency Governance in Practice: Step-by-Step Guide for Sponsors and CROs Introduction to Sponsor Transparency Governance Sponsor transparency governance has emerged as a critical aspect of clinical trial management, especially for schizophrenia clinical trials. The increasing expectations from regulatory authorities and stakeholders placed upon…

Read More “Sponsor Transparency Governance in Practice: Step-by-Step Guide for Sponsors and CROs” »

Sponsor Transparency Governance Playbook for High-Profile and Late-Phase Trials Sponsor Transparency Governance Playbook for High-Profile and Late-Phase Trials Understanding the Importance of Sponsor Transparency in Clinical Trials Sponsor transparency in clinical trials is essential for maintaining the integrity of clinical research and ensuring that stakeholders, including patients, regulators, and the wider community, are adequately informed….

Read More “Sponsor Transparency Governance Playbook for High-Profile and Late-Phase Trials” »

Aligning Sponsor Transparency Governance With ICH, GCP and Transparency Regulations Aligning Sponsor Transparency Governance With ICH, GCP and Transparency Regulations Introduction The regulatory landscape surrounding clinical trials continues to evolve, emphasizing the necessity for sponsors to maintain a robust governance framework surrounding transparency. This step-by-step guide aims to provide clinical operations, regulatory affairs, and medical…

Read More “Aligning Sponsor Transparency Governance With ICH, GCP and Transparency Regulations” »

Inspection and Audit Readiness: Documenting Sponsor Transparency Governance for Regulators Inspection and Audit Readiness: Documenting Sponsor Transparency Governance for Regulators In the ever-evolving landscape of clinical trials, maintaining transparency and governance has become paramount. The success of rfp clinical trials hinges not only on the scientific rigor behind the studies but also on the applicable…

Read More “Inspection and Audit Readiness: Documenting Sponsor Transparency Governance for Regulators” »